One of the main challenges facing the Silver Sulfadiazine Market is the increasing prevalence of resistant strains of bacteria, which can reduce the efficacy of silver sulfadiazine. To address this challenge, the pharmaceutical industry and governments need to work together to develop new and more effective antimicrobial agents that can be used in combination with silver sulfadiazine to overcome bacterial resistance. Another challenge is the high cost of silver sulfadiazine, which can make it inaccessible to patients in low- and middle-income countries. To address this challenge, the pharmaceutical industry and governments need to work together to increase access to silver sulfadiazine in these regions, either through the provision of subsidies or the development of lower-cost formulations.
Read More- https://cmi-latestreportorientedblogs.blogspot.com/2023/02/silver-sulfadiazine-market-global.html
